Cargando…
Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
Luminal A breast cancer has a much better prognosis than other subtypes, with a low risk of local or regional recurrence. However, there is controversy around under- versus overtreatment with regard to adjuvant treatment of node-positive, luminal A breast cancer. The purpose of this study was to ide...
Autores principales: | Park, Sungmin, Lee, Se Kyung, Paik, Hyun-June, Ryu, Jai Min, Kim, Isaac, Bae, Soo Youn, Yu, Jonghan, Kim, Seok Won, Lee, Jeong Eon, Nam, Seok Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459695/ https://www.ncbi.nlm.nih.gov/pubmed/28562530 http://dx.doi.org/10.1097/MD.0000000000006777 |
Ejemplares similares
-
Conditional disease-free survival among patients with breast cancer
por: Paik, Hyun-June, et al.
Publicado: (2017) -
Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women
por: Nam, Sanggeun, et al.
Publicado: (2016) -
Bacterial extracellular vesicles affect endocrine therapy in MCF7 cells
por: An, Jeongshin, et al.
Publicado: (2021) -
Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer
por: Choi, Min-Young, et al.
Publicado: (2016) -
Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors
por: Camacho, Fabian T., et al.
Publicado: (2017)